Robert G Hart Selected Research

Stroke (Strokes)

5/2024	Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE.
1/2024	Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes.
12/2023	Chronic ischemic lesions and presence of patent foramen ovale in young adults with embolic stroke of undetermined source: Results of the young ESUS patient registry.
11/2023	Cerebral Microbleeds and Asundexian in Non-cardioembolic Ischemic Stroke: Secondary Analyses of the PACIFIC-STROKE Randomized Trial.
1/2023	Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials.
8/2022	Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy.
6/2022	Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source: A systematic review and meta-analysis.
4/2022	Functional Abilities of an International Post-Stroke Population: Standard Assessment of Global Everyday Activities (SAGEA) Scale.
1/2022	Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.
1/2021	Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert G Hart Research Topics

Disease

121	Stroke (Strokes) 05/2024 - 10/2002
59	Atrial Fibrillation 01/2023 - 10/2002
48	Ischemic Stroke 05/2024 - 11/2002
47	Hemorrhage 02/2024 - 11/2002
27	Embolic Stroke 01/2024 - 05/2003
16	Embolism (Embolus) 01/2022 - 11/2011
15	Lacunar Stroke 08/2017 - 04/2011
9	Peripheral Arterial Disease 01/2021 - 07/2014
8	Transient Ischemic Attack 01/2024 - 04/2004
8	Infarction (Infarctions) 01/2024 - 09/2014
8	Hypertension (High Blood Pressure) 12/2023 - 07/2005
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 10/2002
6	Brain Infarction 01/2024 - 08/2016
6	Cognitive Dysfunction 12/2020 - 02/2007
6	Myocardial Infarction 10/2020 - 05/2009
6	Carotid Stenosis (Carotid Artery Stenosis) 01/2019 - 06/2006
6	Brain Ischemia (Cerebral Ischemia) 01/2019 - 03/2002
5	Thrombosis (Thrombus) 11/2023 - 04/2014
5	Subdural Hematoma (Subdural Hemorrhage) 08/2021 - 05/2013
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2017
5	Atherosclerosis 10/2020 - 01/2019
5	Vascular Diseases (Vascular Disease) 10/2020 - 05/2003
5	Heart Failure 01/2018 - 03/2011
4	Cerebral Hemorrhage 01/2021 - 07/2005
4	Diabetes Mellitus 11/2019 - 09/2014
4	Infections 01/2019 - 06/2006
4	Chronic Renal Insufficiency 01/2017 - 11/2011
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2014 - 01/2007
4	Thromboembolism 09/2013 - 10/2004
4	Inflammation (Inflammations) 02/2011 - 06/2006
3	Patent Foramen Ovale 12/2023 - 12/2018
3	Carotid Artery Diseases 01/2019 - 01/2015
3	Chronic Kidney Failure (Chronic Renal Failure) 07/2013 - 10/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2011 - 06/2006
3	Sickle Cell Anemia (Hemoglobin S Disease) 02/2011 - 06/2006
3	Migraine Disorders (Migraine) 02/2011 - 06/2006
3	Obesity 02/2011 - 06/2006
3	Sleep Apnea Syndromes (Sleep Apnea) 02/2011 - 06/2006
3	Thrombophilia 02/2011 - 06/2006
3	Substance-Related Disorders (Drug Abuse) 02/2011 - 06/2006
3	Hyperhomocysteinemia 02/2011 - 06/2006
3	Dyslipidemias (Dyslipidemia) 02/2011 - 06/2006
2	Hemorrhagic Stroke 01/2021 - 11/2012
2	Left Ventricular Dysfunction 01/2020 - 01/2018
2	Pathologic Constriction (Stenosis) 06/2018 - 10/2002
2	Venous Thromboembolism 06/2011 - 12/2008
2	Alcoholism (Alcohol Abuse) 06/2006 - 06/2006
2	Headache (Headaches) 04/2006 - 03/2003
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2005 - 11/2002
1	Hyperlipidemias (Hyperlipidemia) 12/2023
1	Cerebral Small Vessel Diseases 11/2023
1	Rheumatic Heart Disease (Rheumatic Heart Diseases) 12/2020

Drug/Important Bio-Agent (IBA)

79	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 10/2002
34	AnticoagulantsIBA 01/2024 - 11/2002
32	RivaroxabanIBA 01/2023 - 12/2013
32	Warfarin (Coumadin)FDA LinkGeneric 12/2020 - 05/2003
17	Clopidogrel (Plavix)FDA Link 01/2018 - 01/2008
16	Vitamin K FDA Link 12/2020 - 11/2002
12	apixabanIBA 02/2024 - 06/2011
9	Factor Xa InhibitorsIBA 01/2023 - 06/2011
9	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 09/2016
7	Dabigatran FDA Link 06/2022 - 06/2011
5	Factor XIa (Coagulation Factor XIa)IBA 05/2024 - 12/2020
5	Irbesartan FDA LinkGeneric 01/2018 - 05/2008
5	spermatogenesis associated factor (SPAF)IBA 04/2007 - 10/2002
4	Lipoprotein(a)IBA 10/2020 - 06/2006
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2016 - 05/2003
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2014 - 10/2002
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 11/2019
3	Oral ContraceptivesIBA 02/2011 - 06/2006
3	Hormones (Hormone)IBA 02/2011 - 06/2006
3	SmokeIBA 02/2011 - 06/2006
3	Heparin (Liquaemin)FDA LinkGeneric 12/2008 - 03/2002
3	von Willebrand FactorIBA 09/2006 - 10/2002
2	betrixabanIBA 01/2023 - 01/2017
2	candesartanIBA 01/2021 - 06/2011
2	N(4)-oleylcytosine arabinosideIBA 09/2020 - 07/2013
2	Proton Pump InhibitorsIBA 01/2019 - 01/2017
2	Pantoprazole (Protonix)FDA LinkGeneric 01/2019 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 10/2014
2	AntithrombinsIBA 06/2014 - 06/2011
2	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2011 - 12/2008
2	Phospholipases (Phospholipase)IBA 06/2006 - 06/2006
2	Lipoproteins (Lipoprotein)IBA 06/2006 - 06/2006
2	P-SelectinIBA 07/2003 - 10/2002
1	Fenofibrate (CiL)FDA LinkGeneric 12/2023
1	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 08/2021
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2021
1	Colchicine FDA LinkGeneric 12/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2020
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 10/2020
1	LipidsIBA 10/2020
1	Proprotein Convertase 9IBA 10/2020
1	Antisense OligonucleotidesIBA 10/2020

Therapy/Procedure

69	Therapeutics 05/2024 - 10/2002
28	Secondary Prevention 01/2022 - 04/2004
1	Stroke Rehabilitation 11/2020